Estradiol and Progesterone Administration After pMCAO Stimulates the Neurological Recovery and Reduces the Detrimental Effect of Ischemia Mainly in Hippocampus

Molecular Neurobiology

Volumn 52, Issue 3, 2015, Pages 1690-1703

  Perez Alvarez, Maria Jose ^a,b,c   Mateos, Laura ^b,d   Alonso, Alvaro ^a   Wandosell, Francisco ^b,c  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^d CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

Estradiol; Glia; Neuroprotection; OGD; Progesterone; Stroke

Indexed keywords

ALPHA CATENIN; BETA CATENIN; ESTRADIOL; GLYCOGEN SYNTHASE KINASE 3; NEURON SPECIFIC NUCLEAR PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROGESTERONE; PROTEIN KINASE B; SYNAPSIN; NEUROPROTECTIVE AGENT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CELL; BRAIN ISCHEMIA; CELL ACTIVATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVITY; GLIOSIS; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPAL STRATUM LUCIDUM; HIPPOCAMPUS; HORMONAL THERAPY; IMMUNOFLUORESCENCE; ISCHEMIC DAMAGE INDEX; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE ASSESSMENT; NEUROPROTECTION; NONHUMAN; PARIETAL CORTEX; PROTEIN PHOSPHORYLATION; PYRIFORM CORTEX; RAT; SIGNAL TRANSDUCTION; SOMATOSENSORY CORTEX; STRATUM RADIATUM; ANIMAL; DISEASE MODEL; DRUG EFFECTS; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIA; METABOLISM; NERVE CELL; WISTAR RAT;

ANIMALS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; ESTRADIOL; HIPPOCAMPUS; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIA; MALE; NEURONS; NEUROPROTECTIVE AGENTS; PROGESTERONE; RATS, WISTAR;

EID: 84942819050     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-014-8963-7     Document Type: Article

References (45)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2013) Heart Disease and Stroke Statistics—2013 Update A Report From the American Heart Association. Circulation 127:e6–e245. doi:10.1161/CIR.0b013e31828124ad
2. Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22(9):391–397. doi:10.1016/S0166-2236(99)01401-0
3. Hossmann K-A (2006) Pathophysiology and therapy of experimental stroke. Cell Mol Neurobiol 26(7):1055–1081. doi:10.1007/s10571-006-9008-1
4. Green A, Odergren T, Ashwood T (2003) Animal models of stroke: do they have value for discovering neuroprotective agents? Trends Pharmacol Sci 24(8):402–408
5. Liu F, McCullough LD (2011) Middle cerebral artery occlusion model in rodents: methods and potential pitfalls. J Biomed Biotechnol. doi:10.1155/2011/464701
6. Alkayed N, Harukuni I, Kimes A, London E, Traystman R, Hurn P (1998) Gender-linked brain injury in experimental stroke. Stroke 29:159–165
7. Takaba H, Fukuda K, Yao H (2004) Substrain differences, gender, and age of spontaneously hypertensive rats critically determine infarct size produced by distal middle cerebral artery occlusion. Cell Mol Neurobiol 24(5):589–598
8. Schumacher M, Mattern C, Ghoumari A, Oudinet JP, Liere P, Labombarda F, Sitruk-Ware R, De Nicola AF, Guennoun R (2014) Revisiting the roles of progesterone and allopregnanolone in the nervous system: resurgence of the progesterone receptors. Prog Neurobiol 113:6–39. doi:10.1016/j.pneurobio.2013.09.004
9. Pérez-Alvarez MJ, Wandosell F (2013) In: Palmeri Rand Grimaudo S (ed) Estradiol in CNS: role in neurodegeneration. Estradiol: synthesis, health effects and drug interaction, 1st edn. Nova, New York, pp 35–68
10. Schumacher M, Guennoun R, Robert F, Carelli C, Gago N, Ghoumari A, Gonzalez Deniselle MC, Gonzalez SL, Ibanez C, Labombarda F, Coirini H, Baulieu E-E, De Nicola AF (2004) Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination. Growth Hormon IGF Res 14:18–33. doi:10.1016/j.ghir.2004.03.007
11. Azcoitia I, Arevalo MA, De Nicola AF, Garcia-Segura LM (2011) Neuroprotective actions of estradiol revisited. Trends Endocrinol Metab 22(12):7. doi:10.1016/j.tem.2011.08.002
12. McCullough L, Hurn P (2003) Estrogen and ischemic neuroprotection: an integrated view. Trends Endocrinol Metab 14(5):228–235. doi:10.1016/S1043-2760(03)00076-6
13. Perez-Alvarez M, Maza M, Anton M, Ordonez L, Wandosell F (2012) Post-ischemic estradiol treatment reduced glial response and triggers distinct cortical and hippocampal signaling in a rat model of cerebral ischemia. J Neuroinflammation 9(1):157. doi:10.1186/1742-2094-9-157
14. Jia J, Guan D, Zhu W, Alkayed NJ, Wang MM, Hua Z, Xua Y (2009) Estrogen inhibits Fas-mediated apoptosis in experimental stroke. Exp Neurol 215:5. doi:10.1016/j.expneurol.2008.09.015
15. Singer CA, Rogers KL, Strickland TM, Dorsa DM (1996) Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci Lett 212(1):13–16. doi:10.1016/0304-3940(96)12760-9
16. Stein DG (2008) Progesterone exerts neuroprotective effects after brain injury. Brain Res Rev 57(2):386–397
17. Baudry M, Bi X, Aguirre C (2013) Progesterone–estrogen interactions in synaptic plasticity and neuroprotection. Neuroscience 239:14. doi:10.1016/j.neuroscience.2012.10.051
18. Wieloch T, Nikolich K (2006) Mechanisms of neural plasticity following brain injury. Curr Opin Neurobiol 16(3):258–264. doi:10.1016/j.conb.2006.05.011
19. Cesca F, Baldelli P, Valtorta F, Benfenati F (2010) The synapsins: key actors of synapse function and plasticity. Prog Neurobiol 91(4):313–348
20. Ohtani-Kaneko R, Iwafuchi M, Iwakura T, Muraoka D, Yokosuka M, Shiga T, Watanabe C (2010) Effects of estrogen on synapsin I distribution in developing hypothalamic neurons. Neurosci Res 66(2):180–188. doi:10.1016/j.neures.2009.10.012
21. Sato K, Akaishi T, Matsuki N, Ohno Y, Nakazawa K (2007) β-Estradiol induces synaptogenesis in the hippocampus by enhancing brain-derived neurotrophic factor release from dentate gyrus granule cells. Brain Res 1150:108–120. doi:10.1016/j.brainres.2007.02.093
22. Carroll JC, Rosario ER, Chang L, Stanczyk FZ, Oddo S, LaFerla FM, Pike CJ (2007) Progesterone and estrogen regulate alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci 27(48):13357–13365. doi:10.1523/jneurosci. 2718-07.2007
23. Jayaraman A, Pike CJ (2014) Differential effects of synthetic progestagens on neuron survival and estrogen neuroprotection in cultured neurons. Mol Cell Endocrinol 384(1–2):12. doi:10.1016/j.mce.2014.01.003
24. Toung TJ, Chen T-Y, Littleton-Kearney MT, Hurn PD, Murphy SJ (2004) Effects of combined estrogen and progesterone on brain infarction in reproductively senescent female rats. J Cereb Blood Flow Metab 24(10):1160–1166
25. Dang J, Mitkari B, Kipp M, Beyer C (2011) Gonadal steroids prevent cell damage and stimulate behavioral recovery after transient middle cerebral artery occlusion in male and female rats. Brain Behav Immun 25(4):715–726. doi:10.1016/j.bbi.2011.01.013
26. Cai W, Zhu Y, Furuya K, Li Z, Sokabe M, Chen L (2008) Two different molecular mechanisms underlying progesterone neuroprotection against ischemic brain damage. Neuropharmacology 55(2):127–138
27. Jiang N, Chopp M, Stein D, Feit H (1996) Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Res 735(1):101–107
28. Yrjänheikki J, Koistinaho J, Kettunen M, Kauppinen RA, Appel K, Hüll M, Fiebich BL (2005) Long-term protective effect of atorvastatin in permanent focal cerebral ischemia. Brain Res 1052(2):174–179
29. Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates, 6th edn. Academic, San Diego, California
30. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez J-Y, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9(7):676–682. doi:10.1038/nmeth.2019
31. Arevalo MA, Santos-Galindo M, Acaz-Fonseca E, Azcoitia I, Garcia-Segura LM (2013) Gonadal hormones and the control of reactive gliosis. Horm Behav 63(2):216–221. doi:10.1016/j.yhbeh.2012.02.021
32. Costain WJ, Rasquinha I, Sandhu JK, Rippstein P, Zurakowski B, Slinn J, MacManus JP, Stanimirovic DB (2007) Cerebral ischemia causes dysregulation of synaptic adhesion in mouse synaptosomes. J Cereb Blood Flow Metab 28(1):99–110
33. Ishrat T, Sayeed I, Atif F, Hua F, Stein DG (2012) Progesterone is neuroprotective against ischemic brain injury through its effects on the phosphoinositide 3-kinase/protein kinase B signaling pathway. Neuroscience 210:442–450. doi:10.1016/j.neuroscience.2012.03.008
34. Johann S, Beyer C (2013) Neuroprotection by gonadal steroid hormones in acute brain damage requires cooperation with astroglia and microglia. J Steroid Biochem Mol Biol 137:71–81. doi:10.1016/j.jsbmb.2012.11.006
35. Aguirre C, Jayaraman A, Pike C, Baudry M (2010) Progesterone inhibits estrogen-mediated neuroprotection against excitotoxicity by down-regulating estrogen receptor-β. J Neurochem 115(5):1277–1287. doi:10.1111/j.1471-4159.2010.07038.x
36. Ozacmak VH, Sayan H (2009) The effects of 17β estradiol, 17α estradiol and progesterone on oxidative stress biomarkers in ovariectomized female rat brain subjected to global cerebral ischemia. Physiol Res 58(6):909–912
37. Toung TJK, Traystman RJ, Hurn PD (1998) Estrogen-mediated neuroprotection after experimental stroke in male rats. Stroke 29:1666–1670
38. Ulbrich C, Zendedel A, Habib P, Kipp M, Beyer C, Dang J (2012) Long-term cerebral cortex protection and behavioral stabilization by gonadal steroid hormones after transient focal hypoxia. J Steroid Biochem Mol Biol 131(1–2):10–16. doi:10.1016/j.jsbmb.2012.01.007
39. Jung-Testas I, Do Thi A, Koenig H, Désarnaud F, Shazand K, Schumacher M, Baulieu EE (1999) Progesterone as a neurosteroid: synthesis and actions in rat glial cells. J Steroid Biochem Mol Biol 69(1–6):97–107. doi:10.1016/S0960-0760(98)00149-6
40. Pawlak J, Karolczak M, Krust A, Chambon P, Beyer C (2005) Estrogen receptor-α is associated with the plasma membrane of astrocytes and coupled to the MAP/Src-kinase pathway. Glia 50(3):270–275. doi:10.1002/glia.20162
41. Habib P, Dreymueller D, Ludwig A, Beyer C, Dang J (2013) Sex steroid hormone-mediated functional regulation of microglia-like BV-2 cells during hypoxia. J Steroid Biochem Mol Biol 138:195–205. doi:10.1016/j.jsbmb.2013.06.003
42. Spruston N, Lübke J, Frotscher M (1997) Interneurons in the stratum lucidum of the rat hippocampus: an anatomical and electrophysiological characterization. J Comp Neurol 385(3):427–440
43. Jacinto E, Facchinetti V, Liu D, Soto N, Wei S, Jung SY, Huang Q, Qin J, Su B (2006) SIN1/MIP1 Maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127(1):125–137
44. Shughrue PJ, Lane MV, Merchenthaler I (1997) Comparative distribution of estrogen receptor-α and -β mRNA in the rat central nervous system. J Comp Neurol 388(4):507–525. doi:10.1002/(sici)1096-9861(19971201)388:4<507::aid-cne1>3.0.co;2-6
45. Kato J, Hirata S, Nozawa A, Yamada-Mouri N (1994) Gene expression of progesterone receptor isoforms in the rat brain. Horm Behav 28(4):454–463. doi:10.1006/hbeh.1994.1043